Literature DB >> 33628995

Aortic dissection during transoesophageal echocardiography: a case report.

Rin Hoshina1, Hideyuki Kishima1, Takanao Mine1, Masaharu Ishihara1.   

Abstract

BACKGROUND: Transoesophageal echocardiography (TOE) is a safe and useful tool. In our case, we are presenting a rare case of a patient with aortic dissection during TOE procedure. CASE
SUMMARY: A 79-year-old woman was referred to our hospital for recurrent paroxysmal atrial fibrillation (AF) with palpitation. Pre-procedural cardiac computed tomography (CT) showed slight dilated ascending aorta (maximum diameter: 40 mm). We decided to perform catheter ablation (CA) for AF, and recommended TOE before the CA because she had a CHADS2 score of 4. On the day before the CA, TOE was performed. Her physical examinations at the time of TOE procedure were unremarkable. At 3 min after probe insertion, there was no abnormal finding of the ascending aorta. At 5 min after the insertion, TOE showed ascending aortic dissection without pericardial effusion. After waking, she had severe back pain and underwent a contrast-enhanced CT. Computed tomography demonstrated Stanford type A aortic dissection extending from the aortic root to the bifurcation of common iliac arteries, and tight stenosis in the right coronary artery (maximum diameter; 49 mm). The patient underwent a replacement of the ascending aorta, and a coronary artery bypass graft surgery for the right coronary artery. DISCUSSION: Transoesophageal echocardiography would have to be performed under sufficient sedation with continuous blood pressure monitoring in patients who have risk factors of aortic dissection. The risk-benefit of TOE must be considered before a decision is made. Depending on the situation, another modality instead of TOE might be required.
© The Author(s) 2020. Published by Oxford University Press on behalf of the European Society of Cardiology.

Entities:  

Keywords:  Aortic dissection; Atrial fibrillation; Case report; Transoesophageal echocardiography

Year:  2020        PMID: 33628995      PMCID: PMC7891243          DOI: 10.1093/ehjcr/ytaa333

Source DB:  PubMed          Journal:  Eur Heart J Case Rep        ISSN: 2514-2119


Before catheter ablation, all patients should be evaluated for risk of aortic dissection. The most probable cause of the aortic dissection in our case report might have been a hypertensive surge. Therefore, transoesophageal echocardiography (TOE) would have to be performed under sufficient sedation with continuous blood pressure monitoring in patients who have risk factors of aortic dissection. The risk–benefit of TOE must be considered before a decision is made. Depending on the situation, another modality instead of TOE might be required.

Introduction

Transoesophageal echocardiography (TOE) is a useful tool that can examine parts of the heart that are difficult to evaluate with transthoracic echocardiography. Transoesophageal echocardiography is performed for detection of thrombi in patients with atrial fibrillation (AF) before the catheter ablation (CA) or cardioversion. However, TOE is an invasive and costly procedure, which provides high-quality images of cardiac structure. Incidence of complications has been reported to be <1% and are very seldom life-threatening. We present a case of a patient with aortic dissection during TOE procedure.

Case presentation

A 79-year-old woman was referred to our hospital for recurrent paroxysmal AF with palpitation. She had a history of transient ischaemic attack and hypertension. She was on candesartan (8 mg once daily), amlodipine (2.5 mg once daily), and apixaban (2.5 mg twice daily). Her body weight was 39 kg, and height was 159 cm. All laboratory findings were within normal range. Electrocardiogram showed normal sinus rhythm and no evidence of ischaemic changes or ST elevation. Chest X-ray was unremarkable. She showed a dilated left atrium (LA diameter: 31 mm, LA volume index: 35 mL/m2) and normal left ventricular systolic function (left ventricular ejection fraction: 76%). Pre-procedural cardiac computed tomography (CT) showed four pulmonary veins, and slight dilated ascending aorta (maximum diameter: 40 mm, ) with mild calcific plaques. We decided to perform CA for AF, and recommended TOE before the CA to assess the presence or absence of left atrial appendage thrombus (LAAT) because she had a CHADS2 score of 4. (A) Pre-procedural cardiac computed tomography showed no abnormal finding of the aorta (maximum diameter: 40 mm). (B) Cardiac computed tomography showed Stanford type A aortic dissection (white arrows, maximum diameter: 49 mm) after transoesophageal echocardiography. On the day before the CA, TOE was performed with an iE33 (Philips Medical System, Andover, MA, USA) with a 4-MHz OmniPlane probe. After local pharyngeal anaesthesia with lidocaine spray, the patient was placed in the left lateral position and midazolam (3 mg) was administered for mild sedation. Her physical examination showed a regular pulse rate (PR) of 62 b.p.m., a blood pressure (BP) of 117/84 mmHg, and a normal temperature. Her physical examinations at the time of TOE procedure were unremarkable. At 3 min after probe insertion, she had a BP of 117/84 mmHg, PR of 62 b.p.m., and there was no abnormal finding of the ascending aorta at that time (). We then administered additional midazolam (2 mg) due to body movement. At 5 min after the insertion, we confirmed that the absence of LAAT (BP: 95/40 mmHg, PR: 76 b.p.m.). However, TOE showed ascending aortic dissection without pericardial effusion (). The probe was removed at the end of anaesthesia after flumazenil (0.2 mg) infusion. After waking, she had severe back pain, and underwent a contrast-enhanced cardiac CT. Cardiac CT demonstrated Stanford type A aortic dissection extending from the aortic root to the bifurcation of common iliac arteries, and tight stenosis in the right coronary artery (maximum diameter; 49 mm, ). An electrocardiogram showed a normal sinus rhythm and no ST-segment abnormalities. The patient underwent a replacement of the ascending aorta, and a coronary artery bypass graft surgery for the right coronary artery. After surgery, the patient gradually stabilized, and she was transferred to a rehabilitation hospital on the 60th postoperative day. After 9 months of follow-up, the patient is doing well. (A) Transoesophageal echocardiography showed no abnormal finding of the ascending aorta at 3 min after probe insertion. (B) Transoesophageal echocardiography demonstrated ascending aortic dissection (white arrows) at 5 min after probe insertion.

Discussion

Transoesophageal echocardiography before the CA for AF has become a routine clinical practice to exclude LAAT. Transoesophageal echocardiography provides high-quality images of cardiac structure and function. However, it is an invasive and costly procedure with the risk of complications such as trauma, vagal reactions or aspiration due to probe insertion, allergic reactions to topical anaesthesia, and hypotension or hypoxia due to conscious sedation. Recently, Ramalingam et al. investigated the complications in patients who underwent peri-operative TOE. Of 22 314 examinations, there were 17 patients (0.08%) with a major complication (palatal injury or gastro-oesophageal disruption), and there were seven deaths (0.03%). Various predictive factors of aortic dissection have been reported. A recent study reported factors including advanced age, male gender, long-term history of hypertension, the presence of aortic aneurysm, and genetic connective tissue disorder such as Marfan, Loeys–Dietz, or Ehlers–Danlos syndrome. Of these factors, our patient was of advanced age and had a history of hypertension. Moreover, CT before the TOE showed a dilated ascending aorta (40 mm). Furthermore, aortic dissection has been reported in several iatrogenic conditions such as intubation or bronchoscopy. Kim et al. reported a case of a 43-year-old woman with aortic dissection who died during TOE. She had Marfan syndrome, and presented with acute chest pain before the TOE. During the intubation, the patient developed acute pericardial tamponade which resulted in death in spite of cardiopulmonary resuscitation. Very few reports have focused on aortic dissection during TOE. The most probable cause of the aortic dissection in our case report might have been a hypertensive surge. However, this cannot be verified as we did not use continuous BP measurement during the TOE procedure. Therefore, the mechanism linking TOE and aortic dissection remains unclear. Aortic dissection is a very rare but life-threatening complication of TOE with a lethality rate of 1–2% per hour after symptom onset in untreated patients. Therefore, indication of TOE has to be carefully decided. Yamashita et al. evaluated clinical predictors of LAAT in patients with AF. In their study, none of the 136 patients with paroxysmal lone AF who were below 60 years had LAAT thrombus prior to CA. Scherr et al. also investigated the incidence and predictors of LAAT in 585 patients with AF. Left atrial appendage thrombus was present in 0.3% of patients with CHADS2 scores of 0. According to their findings, it might be reasonable to omit TOE in younger paroxysmal lone AF patients with low CHADS2 score. However, our case required TOE before the CA because she had a CHADS2 score of 4 (history of transient ischaemic attack, hypertension, and older age). In our case, the patient was a 79-year-old chronic hypertension that was not very well controlled (suggested by elevated left ventricular ejection fraction: 76%), and having calcific plaques in an aorta. Moreover, the size of ascending aorta (aortic height index: 4.0 cm/1.59 m = 2.52 cm/m) indicates moderate risk of aortic dissection according to previous report. Therefore, TOE would have to be performed under sufficient sedation with continuous BP monitoring in patients who have risk factors of aortic dissection. Furthermore, depending on the situation, another modality instead of TOE might be required.

Conclusions

The risk–benefit of TOE must be considered before a decision is made. Particular attention is required for patients with risk of aortic dissection during TOE.

Lead author biography

Rin Hoshina, MD, graduated from Hyogo College of Medicine, Japan. She has been a doctor for 3 years in Department of Cardiovascular and Renal Medicine at Hyogo College of Medicine. She is interested in pursuing catheter ablation and further career in cardiology.

Supplementary material

Supplementary material is available at European Heart Journal - Case Reports online. Slide sets: A fully edited slide set detailing this case and suitable for local presentation is available online as Supplementary data. Consent: The author/s confirm that written consent for submission and publication of this case report including image(s) and associated text has been obtained from the patient in line with COPE guidance. Conflict of interest: none declared. Click here for additional data file.
The physical examination showed a regular pulse rate of 62 b.p.m. and a blood pressure of 117/84 mmHg before probe insertion
At 3 min after probe insertion transoesophageal echocardiography (TOE) showed no abnormal finding of ascending aorta
At 5 min after probe insertion TOE showed ascending aortic dissection without pericardial effusion
Immediate computed tomography chest: Stanford type A aortic dissection extending from the aortic root to the bifurcation of common iliac arteries and tight stenosis in the right coronary artery
Emergent replacement of the ascending aorta and a coronary artery bypass graft surgery for right coronary artery
On the 60th postoperative day she was transferred to the rehabilitation hospital
  8 in total

1.  Transesophageal echocardiography for thrombus screening prior to left atrial catheter ablation.

Authors:  Eiji Yamashita; Hiroto Takamatsu; Hiroshi Tada; Hiroyuki Toide; Hiroki Okaniwa; Naoki Takemura; Takehito Sasaki; Yuko Miki; Etsuko Fuke; Tatsuya Hayashi; Tamotsu Sakamoto; Koki Nakamura; Rie Fukazawa; Chizuru Sato; Koji Goto; Kenichi Kaseno; Koji Kumagai; Shigeto Naito; Hiroshi Hoshizaki; Shigeru Oshima
Journal:  Circ J       Date:  2010-04-20       Impact factor: 2.993

2.  Complications related to peri-operative transoesophageal echocardiography - a one-year prospective national audit by the Association of Cardiothoracic Anaesthesia and Critical Care.

Authors:  G Ramalingam; S-W Choi; S Agarwal; G Kunst; R Gill; S N Fletcher; A A Klein
Journal:  Anaesthesia       Date:  2019-06-24       Impact factor: 6.955

3.  Accuracy of biplane transesophageal echocardiography in detecting left atrial thrombus.

Authors:  D Fatkin; G Scalia; N Jacobs; D Burstow; D Leung; W Walsh; M Feneley
Journal:  Am J Cardiol       Date:  1996-02-01       Impact factor: 2.778

Review 4.  Acute aortic dissection: pathogenesis, risk factors and diagnosis.

Authors:  Joanna Gawinecka; Felix Schönrath; Arnold von Eckardstein
Journal:  Swiss Med Wkly       Date:  2017-08-25       Impact factor: 2.193

5.  Height alone, rather than body surface area, suffices for risk estimation in ascending aortic aneurysm.

Authors:  Mohammad A Zafar; Yupeng Li; John A Rizzo; Paris Charilaou; Ayman Saeyeldin; Camilo A Velasquez; Ahmed M Mansour; Syed Usman Bin Mahmood; Wei-Guo Ma; Adam J Brownstein; Maryann Tranquilli; Julia Dumfarth; Panagiotis Theodoropoulos; Kabir Thombre; Maryam Tanweer; Young Erben; Sven Peterss; Bulat A Ziganshin; John A Elefteriades
Journal:  J Thorac Cardiovasc Surg       Date:  2017-12-06       Impact factor: 5.209

6.  Incidence and predictors of left atrial thrombus prior to catheter ablation of atrial fibrillation.

Authors:  Daniel Scherr; Darshan Dalal; Karuna Chilukuri; Jun Dong; David Spragg; Charles A Henrikson; Saman Nazarian; Alan Cheng; Ronald D Berger; Theodore P Abraham; Hugh Calkins; Joseph E Marine
Journal:  J Cardiovasc Electrophysiol       Date:  2008-10-27

7.  [A Patient with Difficult Airway who Died from Acute Aortic Dissection after Intubation].

Authors:  Yoolim Yamada; Shinichi Inomata; Makoto Tanaka
Journal:  Masui       Date:  2017-04

8.  Cardiac tamponade during transesophageal echocardiography in the patient of circumferential aortic dissection.

Authors:  C M Kim; S C Yu; S J Hong
Journal:  J Korean Med Sci       Date:  1997-06       Impact factor: 2.153

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.